Verici Dx Plc
LSE:VRCI

Watchlist Manager
Verici Dx Plc Logo
Verici Dx Plc
LSE:VRCI
Watchlist
Price: 0.725 GBX -3.33%
Market Cap: 11m GBX

Wall Street
Price Targets

VRCI Price Targets Summary
Verici Dx Plc

Wall Street analysts forecast VRCI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VRCI is 2.958 GBX with a low forecast of 2.929 GBX and a high forecast of 3.045 GBX.

Lowest
Price Target
2.929 GBX
304% Upside
Average
Price Target
2.958 GBX
308% Upside
Highest
Price Target
3.045 GBX
320% Upside
Verici Dx Plc Competitors:
Price Targets
ZEAL
Zealand Pharma A/S
60% Upside
BNTX
BioNTech SE
46% Upside
PASG
Passage Bio Inc
242% Upside
LTRN
Lantern Pharma Inc.
573% Upside
PRME
Prime Medicine Inc
90% Upside
CUV
Clinuvel Pharmaceuticals Ltd
107% Upside
1801
Innovent Biologics Inc
36% Upside
IPH
Innate Pharma SA
212% Upside

Revenue
Forecast

Revenue Estimate
Verici Dx Plc

The compound annual growth rate of Verici Dx Plc's revenue for the next 1 year is 27%.

N/A
Past Growth
27%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Verici Dx Plc

Operating Income forecast
is not available for
Verici Dx Plc

Net Income
Forecast

Net Income Estimate
Verici Dx Plc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VRCI's stock price target?
Price Target
2.958 GBX

According to Wall Street analysts, the average 1-year price target for VRCI is 2.958 GBX with a low forecast of 2.929 GBX and a high forecast of 3.045 GBX.

What is Verici Dx Plc's Revenue forecast?
Projected CAGR
27%

The compound annual growth rate of Verici Dx Plc's revenue for the next 1 year is 27%.

Back to Top